Evaluation of Financial Failure of Healthcare Companies Traded in BIST with Fulmer H and Springate S Score Models

Abstract

Financial failure begins when companies fail to meet their obligations regarding assets and liabilities, according to modern finance principles. It will be ensured that the financial performances of the health companies traded on the BIST will be determined, and the health expenditures that concern the whole society will be transferred to the appropriate areas by considering the maximum social benefit. In this direction, it is aimed at evaluating whether companies operating in the field of health and whose shares are traded in Borsa Istanbul carry the risk of financial failure. For this purpose, using the financial statement data of 8 companies in the BIST 100 index for the period 2019–2022, financial risk situations were examined with Fulmer H and Springate S score models. As a result of the research, it has been determined that all but one of the health companies traded on the BIST are not facing financial failure.